Human Microbiome and Healthcare Associated Infections - Nursing Home Dwelling Older Veterans

PHASE4CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

August 12, 2014

Primary Completion Date

September 22, 2015

Study Completion Date

September 22, 2015

Conditions
Human Microbiome
Interventions
DRUG

Intranasal Mupirocin and Topical Chlorhexidine

Antimicrobial antiseptic skin cleanser (4% chlorhexidine) for daily use on Day 1, 3 and 5 of Week 8 of the study. BACTROBAN NASAL ointment (mupirocin calcium ointment, 2%) for use intranasally twice-daily on Day 1, 2, 3, 4 and 5 of Week 8 of the study.

Trial Locations (2)

21218

Loch Raven VA Community Living Center, Baltimore

21902

Perry Point VA Community Living Center, Perry Point

All Listed Sponsors
collaborator

VA Office of Research and Development

FED

lead

University of Maryland, Baltimore

OTHER

NCT04218799 - Human Microbiome and Healthcare Associated Infections - Nursing Home Dwelling Older Veterans | Biotech Hunter | Biotech Hunter